Arcadia Biosciences, Inc. (RKDA)
0.4726
0.00 (0.00%)
USD |
NASDAQ |
Sep 04, 16:00
0.4653
-0.01
(-1.54%)
After-Hours: 20:00
Arcadia Biosciences Shareholders Equity (Quarterly) : 0.633M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.633M |
| March 31, 2026 | 2.885M |
| December 31, 2025 | 4.14M |
| September 30, 2025 | 5.443M |
| June 30, 2025 | 4.533M |
| March 31, 2025 | 8.905M |
| December 31, 2024 | 6.223M |
| September 30, 2024 | 10.29M |
| June 30, 2024 | 11.70M |
| March 31, 2024 | 10.62M |
| December 31, 2023 | 12.84M |
| September 30, 2023 | 15.54M |
| June 30, 2023 | 17.87M |
| March 31, 2023 | 16.82M |
| December 31, 2022 | 21.03M |
| September 30, 2022 | 25.07M |
| June 30, 2022 | 26.81M |
| March 31, 2022 | 30.26M |
| December 31, 2021 | 31.09M |
| September 30, 2021 | 39.84M |
| June 30, 2021 | 41.64M |
| March 31, 2021 | 44.50M |
| December 31, 2020 | 27.72M |
| September 30, 2020 | 11.28M |
| June 30, 2020 | 12.12M |
| Date | Value |
|---|---|
| March 31, 2020 | 11.02M |
| December 31, 2019 | 7.705M |
| September 30, 2019 | 13.54M |
| June 30, 2019 | 8.286M |
| March 31, 2019 | 0.633M |
| December 31, 2018 | 12.82M |
| September 30, 2018 | 12.92M |
| June 30, 2018 | 8.13M |
| March 31, 2018 | 0.667M |
| December 31, 2017 | 8.007M |
| September 30, 2017 | 10.67M |
| June 30, 2017 | 14.76M |
| March 31, 2017 | 18.37M |
| December 31, 2016 | 22.20M |
| September 30, 2016 | 27.51M |
| June 30, 2016 | 31.29M |
| March 31, 2016 | 35.48M |
| December 31, 2015 | 40.22M |
| September 30, 2015 | 43.83M |
| June 30, 2015 | 47.93M |
| March 31, 2015 | -7.299M |
| December 31, 2014 | -1.885M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Moolec Science SA | -- |
| Zivo Bioscience, Inc. | -3.382M |
| PMGC Holdings, Inc. | 16.74M |
| Archer-Daniels-Midland Co. | 23.57B |
| Alico, Inc. | 104.83M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 5.893M |
| Total Liabilities (Quarterly) | 5.26M |
| Current Ratio | 3.487 |
| Net Debt Paydown Yield | 0.28% |